| Dr Brandi Erichsen, OD | |
|
202 Nw 15th St, Abilene, KS 67410-1579 | |
| (785) 263-2020 | |
| Not Available |
| Full Name | Dr Brandi Erichsen |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 9 Years |
| Location | 202 Nw 15th St, Abilene, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932559374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2027 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kyler Knobbe Od Llc | 1951694298 | 3 |
News Archive
Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).
Recent clinical trials show that a new colon cancer screening technique created by Northwestern University researchers has a high enough sensitivity that it could potentially be as or more successful than a colonoscopy in screening for colon cancer.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has initiated the Collaborative Influenza Vaccine Innovation Centers program, a new network of research centers that will work together in a coordinated, multidisciplinary effort to develop more durable, broadly protective and longer-lasting influenza vaccines.
Researchers at New York University's Center for Neural Science and the Baylor College of Medicine have identified a protein that when removed from mice results in behaviors that are akin to those with autism and obsessive-compulsive disorders.
› Verified 6 days ago
| Provider Name | Kyler Knobbe Od Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326492190 PECOS PAC ID: 1951694298 Enrollment ID: O20160725002698 |
News Archive
Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).
Recent clinical trials show that a new colon cancer screening technique created by Northwestern University researchers has a high enough sensitivity that it could potentially be as or more successful than a colonoscopy in screening for colon cancer.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has initiated the Collaborative Influenza Vaccine Innovation Centers program, a new network of research centers that will work together in a coordinated, multidisciplinary effort to develop more durable, broadly protective and longer-lasting influenza vaccines.
Researchers at New York University's Center for Neural Science and the Baylor College of Medicine have identified a protein that when removed from mice results in behaviors that are akin to those with autism and obsessive-compulsive disorders.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brandi Erichsen, OD 202 Nw 15th St, Abilene, KS 67410-1579 Ph: (785) 263-2020 | Dr Brandi Erichsen, OD 202 Nw 15th St, Abilene, KS 67410-1579 Ph: (785) 263-2020 |
News Archive
Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).
Recent clinical trials show that a new colon cancer screening technique created by Northwestern University researchers has a high enough sensitivity that it could potentially be as or more successful than a colonoscopy in screening for colon cancer.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has initiated the Collaborative Influenza Vaccine Innovation Centers program, a new network of research centers that will work together in a coordinated, multidisciplinary effort to develop more durable, broadly protective and longer-lasting influenza vaccines.
Researchers at New York University's Center for Neural Science and the Baylor College of Medicine have identified a protein that when removed from mice results in behaviors that are akin to those with autism and obsessive-compulsive disorders.
› Verified 6 days ago
Dr. Jenee' Barth, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 311 Nw 3rd, Abilene, KS 67410 Phone: 785-263-2020 | |
Family Eye Care Of Abilene, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 311 Nw 3rd St, Abilene, KS 67410 Phone: 785-263-2020 Fax: 785-263-1290 | |
Dr. Jeffrey L Luty, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 N Brown St Ste A, Abilene, KS 67410 Phone: 785-263-3651 Fax: 785-263-3561 | |
Jeffrey L Luty Od, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 1000 N Brown St Ste A, Abilene, KS 67410 Phone: 785-263-3651 Fax: 785-263-3561 | |
Dr. Jon D. Thayer, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 311 Nw 3rd St, Abilene, KS 67410 Phone: 785-263-2020 Fax: 785-263-1290 | |
Mr. Jarad M. Waite, O.D. PA Optometrist Medicare: Accepting Medicare Assignments Practice Location: 311 Nw 3rd St, Abilene, KS 67410 Phone: 785-263-2020 Fax: 785-263-1290 |